SRMC offers new tech to treat prostate cancer
Minimally invasive procedure allows patients to resume normal activities
PETERSBURG — Southside Regional Medical Center, SRMC, has added a new technology for men choosing to undergo radiation therapy for prostate cancer. This new product is a protective spacer used between the prostate and the rectum. Interventional radiologist Adam McLaurin, D.O., in collaboration with radiation oncologist David Penberthy, M.D., were able to bring this innovative technology to SRMC in June 2018.
The procedure has been clinically proven to reduce the risk of side effects during and after radiation treatment. By acting as a spacer, the product pushes the rectum away from the prostate so damage to the rectum is reduced or even eliminated, helping to ensure that rectal, urinary and sexual quality of life will be maintained.
“When treating a tumor with radiation you want a certain dose to the tumor, but as little radiation exposure to the normal surrounding tissues as possible to reduce side effects. The interventional radiologist can inject this product around the prostate, creating a buffer that decreases the amount of radiation to the normal tissues close by. This decreases side effects, short and long term, based on a threeyear study,” says Tracey Tatum, MS, FNP, director of oncology at SRMC.
It is a minimally invasive outpatient procedure with local or general anesthesia. Patients can immediately resume their normal activities. The product stays in place for approximately three months and is then naturally absorbed and cleared in the urine in about six months.
SRMC’s Accredited Cancer Center delivers a range of cancer care services, from early screening and preventive education to diagnosis, treatment and recovery. Learn more at www.srmconline.com/ cancer-care-services or call 804-765-5850.